Combining Trazodone and Bupropion (Wellbutrin)
Trazodone and bupropion can be safely combined, and this combination is commonly used in clinical practice, particularly when treating depression with comorbid insomnia or when augmenting antidepressant response. 1
Safety Profile of the Combination
The combination has a well-established safety record supported by extensive clinical experience. No specific drug-drug interactions exist between trazodone and bupropion that would contraindicate their concurrent use 2, 3. The FDA labeling for bupropion does not list trazodone as a contraindicated medication, and clinical guidelines explicitly recognize this combination as a therapeutic option 1.
Key Safety Considerations:
Seizure risk: Bupropion lowers the seizure threshold in a dose-dependent manner. The maximum daily dose should not exceed 450 mg (typically 150 mg twice daily for sustained-release formulations). Avoid this combination in patients with seizure disorders, eating disorders (bulimia/anorexia), or those abruptly discontinuing alcohol or benzodiazepines 4, 2.
Serotonin syndrome: While theoretically possible given trazodone's serotonergic activity, this is extremely rare with this specific combination. One case report exists of serotonin syndrome occurring with trazodone, bupropion, and quetiapine in the context of electroconvulsive therapy 5, but this involved multiple confounding factors and is not representative of typical clinical use.
CNS effects: Bupropion is activating while trazodone is sedating—these effects can be complementary rather than problematic 6.
Dosing Recommendations
Bupropion Dosing:
- Start: 150 mg once daily in the morning
- Titrate: After 3 days, increase to 150 mg twice daily if tolerated
- Maximum: 300 mg/day for most patients (450 mg/day maximum, but use caution)
- Timing: Give second dose before 3 PM to minimize insomnia 4, 2
Trazodone Dosing:
- For insomnia augmentation: 25-100 mg at bedtime (much lower than antidepressant doses)
- For depression: 150 mg/day initially, can increase by 50 mg every 3-4 days
- Maximum: 400 mg/day for outpatients, 600 mg/day for inpatients
- Administration: Take shortly after a meal or light snack 3
Clinical Rationale for Combination
This combination addresses complementary mechanisms:
- Bupropion provides dopamine-norepinephrine reuptake inhibition (activating, improves energy and motivation) 4
- Trazodone provides serotonergic modulation and sedation (improves sleep, reduces anxiety) 1
The combination is particularly useful when:
- Primary antidepressant (bupropion) causes insomnia
- Depression presents with both low energy and poor sleep
- Augmentation strategy is needed for partial response 1
Evidence from Clinical Practice
Real-world prescribing data demonstrates this is a common and accepted combination. A retrospective analysis found that 23% of patients on bupropion were concurrently prescribed trazodone, indicating widespread clinical acceptance of this combination 7. Research on combined formulations (Lorexys) containing both medications for hypoactive sexual desire disorder showed good tolerability without concerning sedative effects 8, 9.
Monitoring Requirements
- Blood pressure: Both medications can affect blood pressure; monitor at baseline and periodically 2
- Mood changes: Watch for activation of mania/hypomania, worsening depression, or suicidal ideation 2, 3
- Seizure precautions: Educate patients about seizure risk factors and warning signs
- Daytime sedation: Assess for carryover sedation from trazodone, particularly in elderly patients
Common Pitfalls to Avoid
Using trazodone doses that are too high: For insomnia augmentation, 25-100 mg is typically sufficient; higher doses increase side effects without additional benefit 1
Timing bupropion incorrectly: Second dose after 3 PM increases insomnia risk 4
Abrupt discontinuation: Taper both medications gradually when discontinuing to avoid withdrawal symptoms 3
Ignoring contraindications: Screen carefully for seizure risk factors, eating disorders, and bipolar disorder before initiating bupropion 2
Inadequate trial duration: Allow 4-8 weeks for full antidepressant effect before concluding treatment failure 4